Page 38 - 2022-34-中国全科医学
P. 38

http://www.chinagp.net   E-mail:zgqkyx@chinagp.net.cn  ·4259·


                                                                                           • 医学循证 •


           老年高血压临床指南现状分析及质量评价


                                        1
                                1
                         1
                 1
           田昕彤 ,马腾 ,孙璇 ,杨继 ,赵英强                  2*                                           扫描二维码
                                                                                               查看原文
               【摘要】 背景 高血压多发于老年人群;随人口老龄化程度的日益加深,老年高血压患病率呈上升趋势。老
           年高血压的早期预防和诊疗至关重要,而开发高质量的临床实践指南是提升老年高血压预防及诊治水平的重要途径。
           目的 分析国内外老年高血压诊疗与管理指南的现状,并对其进行方法学质量评价。方法 于 2021 年 12 月,计算
           机检索中国知网、维普中文科技期刊全文数据库、万方数据知识服务平台、中国生物医学文献服务系统、PubMed、
           EmBase、医脉通,以及美国国立临床实践指南文库(NGC)、国际指南协作网(GIN)、英国国家卫生与临床优化
           研究所(NICE)等网站,获取老年高血压临床指南。检索时限均为建库至 2021 年 12 月。由 2 名研究者独立筛选文
           献、提取资料后,由 4 名研究者采用 AGREE Ⅱ对纳入指南的方法学质量进行评价,并汇总指南的推荐意见。结果
           共纳入 11 部指南,其中 7 部来源于中国,2 部来源于美国,2 部来源于欧洲。11 部指南在范围和目的、参与人员、制
           定的严谨性、表达的清晰性、应用性和编辑独立性 6 个领域的平均标准化百分比分别为 50.13%、24.24%、18.51%、
           54.03%、11.36%、30.30%;5 部指南推荐级别为 B,6 部指南推荐级别为 C。主要推荐意见涉及 3 个方面,分别为老
           年高血压的药物治疗、非药物治疗与持续性健康管理。结论 老年高血压临床指南总体质量不高。未来,在开发老年
           高血压临床指南时,应提升对参与人员、制定的严谨性、应用性三大领域的关注度和重视程度,以使指南能更好地服
           务于临床。
               【关键词】 高血压;老年人;临床实践指南;专家共识;质量评价;AGREE Ⅱ;循证医学
               【中图分类号】 R 544.1 R 4 【文献标识码】 A DOI:10.12114/j.issn.1007-9572.2022.0323
               田昕彤,马腾,孙璇,等 . 老年高血压临床指南现状分析及质量评价[J]. 中国全科医学,2022,25(34):
           4259-4266,4285.[www.chinagp.net]
               TIAN X T,MA T,SUN X,et al. Clinical guidelines analysis and quality assessment of guidelines for hypertension in the
           elderly[J]. Chinese General Practice,2022,25(34):4259-4266,4285.

                                                                                                  1
           Clinical Guidelines Analysis and Quality Assessment of Guidelines for Hypertension in the Elderly TIAN Xintong ,MA
              1
                        1
                                1
           Teng ,SUN Xuan ,YANG Ji ,ZHAO Yingqiang 2*
           1.Graduate School,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China
           2.Cardiovascular Department,Second Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300250,
           China
           *
           Corresponding author:ZHAO Yingqiang,Professor,Doctoral supervisor;E-mail:zhaoyingqiang1000@126.com
               【Abstract】 Background Older people are a group susceptible to hypertension,and among whom hypertension
           prevalence is increasing as population aging aggravates. Early prevention,diagnosis and treatment of hypertension in the elderly
           are very important,which can be enhanced by an important way,namely developing high-quality clinical practice guidelines.
           Objective To perform an analysis of the guidelines regarding the diagnosis and management of hypertension in the elderly,
           and to assess their methodological quality. Methods In December 2021,we searched for clinical guidelines for hypertension
           in the elderly in databases of CNKI,CQVIP,WanFang Data,SinoMed,PubMed,EmBase and Medlive,as well as in the
           official websites of the National Guideline Clearing house,the Guidelines International Network and the National Institute for
           Health and Care Excellence from inception to December 2021. Two reviewers independently conducted literature screening and
           data extraction. Four reviewers independently evaluated the methodological quality of included guidelines using the AGREE Ⅱ .
           Recommendations from each guideline were retrieved. Results A total of 11 guidelines were included:seven are Chinese
           guidelines,two are US guidelines and the other two are European guidelines. The mean standardized domains scores of the
           AGREE Ⅱ instrument in assessing the overall guideline quality were as follows:50.13% for scope and purpose,24.24% for
           stakeholder involvement,18.51% for rigour of development,54.03% for clarity of presentation,11.36% for applicability

               基金项目:国家重点研发计划(2019YFC1710005)——东部中心城市社区心脑血管疾病中医防控模式研究及示范基地建设
               1.301617 天津市,天津中医药大学研究生院 2.300250 天津市,天津中医药大学第二附属医院心血管科
               *
               通信作者:赵英强,教授,博士生导师;E-mail:zhaoyingqiang1000@126.com
               本文数字出版日期:2022-09-29
   33   34   35   36   37   38   39   40   41   42   43